ORI are delighted to confirm the re-start of the NIHR funded CLEAT study, a randomised controlled trial to compare the CHAIN programme with usual physiotherapy care in the treatment of hip osteoarthritis.
The purpose of the CLEAT study is to investigate whether people who receive an 8-week education and static cycling treatment have an improvement in their hip function and less pain than those patients who receive usual physiotherapy treatment within the NHS. The results from this study will be used to inform and influence decisions around care for hip osteoarthritis in the future.
The NIHR funded study was first launched in February 2020 but was paused shortly after due to the Covid-19 pandemic. Since then, Norbert Bokor has joined the ORI team as CLEAT trial manager and oversees the day-to-day management of the study.
So far, 18 participants have completed their 8-week follow up, with another 20 participants starting the study this week.
Deputy Head of ORI, Professor Tom Wainwright said: “It is fantastic to have re-started the study and to welcome Norbert to the team. Norbert has settled into the role brilliantly, and the whole ORI team have been fantastic in pulling together to get the study going again. We are now looking forward to increasing recruitment over the coming months”.